These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 17961549

  • 1. The effect of taurolidine on experimental thrombus formation.
    Kaptanoglu L, Kucuk HF, Colak E, Kurt N, Bingul SM, Akyol H, Torlak OA, Yazici F.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):238-41. PubMed ID: 17961549
    [Abstract] [Full Text] [Related]

  • 2. Combinations of low doses of unfractionated heparin and of low-molecular-weight heparin prevent experimental venous thrombosis.
    Carelli G, Maffei FH, Mattar L, Ferrari IC, Thomazini-Santos IA, de Carvalho LR.
    Pathophysiol Haemost Thromb; 2005 Jan 14; 34(6):263-8. PubMed ID: 16772737
    [Abstract] [Full Text] [Related]

  • 3. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar 14; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 4. An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis.
    Tarhan OR, Barut I, Sezik M.
    J Surg Res; 2008 Jan 14; 144(1):151-7. PubMed ID: 17981298
    [Abstract] [Full Text] [Related]

  • 5. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
    Farias WR, Nazareth RA, Mourão PA.
    Thromb Haemost; 2001 Dec 14; 86(6):1540-6. PubMed ID: 11776325
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of mesenteric lymph duct ligation on coagulability of blood after acute loss of blood in rats].
    Zhao ZG, Liu CY, Zhang YP, Zhang J, Zhao YQ, Niu CY.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Dec 14; 21(12):708-10. PubMed ID: 20042133
    [Abstract] [Full Text] [Related]

  • 16. Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis--a comparison with low molecular weight heparin.
    Holst J, Lindblad B, Bergqvist D, Nordfang O, Ostergaard PB, Petersen JG, Nielsen G, Hedner U.
    Thromb Haemost; 1994 Feb 14; 71(2):214-9. PubMed ID: 8191401
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H, Ozbilge H, Oguz E, Gurkan T.
    Curr Eye Res; 2005 Mar 14; 30(3):155-61. PubMed ID: 15804740
    [Abstract] [Full Text] [Related]

  • 20. Antithrombotic effect of two low molecular weight thrombin inhibitors and a low-molecular weight heparin in a caval vein thrombosis model in the rat.
    Eriksson BI, Carlsson S, Halvarsson M, Risberg B, Mattsson C.
    Thromb Haemost; 1997 Nov 14; 78(5):1404-7. PubMed ID: 9408027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.